Cannabis Law Report

JULY 21, 2021

The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinical trial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.

Clinical Trials 105

Clinical Trials Chronic Pain Research and Development Treatment 105

Cannabis Law Report

SEPTEMBER 14, 2021

Those insights will help bring products to market that are specifically formulated based on rigorous evidence to address need states like chronic pain, restful sleep, and general health and well-being. About Radicle Science.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

JULY 4, 2021

Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. When you use these substances, they can impact things like memory, sleep, mood, and pain. THC will mostly bind with the receptors in your brain, which control mood, pain, and other similar feelings.

THC 105

THC CBD Legalization Oil 105

The Cannigma

DECEMBER 12, 2022

Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine. This stage lasts for 8 to 20 hours.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

AUGUST 2, 2021

Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain. Key findings from the pre-clinical trial are as follows: SCI-160 significantly alleviates pain up to 6 hours after injection as compared with vehicle-treated animals. TEL AVIV, Israel , Aug.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. There’s the one drug, one target, cannabis is multiple active ingredients and acts on multiple targets in the body.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Data collection. Pain and chronic pain were the most common conditions mentioned over the time period and were referred to in 62% of all articles.

Research and Development 52

Research and Development Medicine Access Media 52